We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Low Serum Creatinine Associated with Diabetes Risk

By LabMedica International staff writers
Posted on 02 May 2019
Creatinine is the only metabolite of creatine phosphate in the skeletal muscle and under the steady state; it is created at a relatively constant rate by the body depending on the total skeletal muscle mass.

Because of the close association between muscle mass and creatinine (correlation coefficient equal to or greater than 0.7), serum creatinine is also used as an inexpensive, easily available surrogate of muscle mass when the kidney functions are stable and protein intake is normal.

Scientists at the National Center for Global Health and Medicine (Tokyo, Japan) and their colleagues conducted a prospective analysis using data from 31,343 men aged between 20 to 64 years without diabetes at baseline from the Japan Epidemiology Collaboration on Occupational Health Study. More...
Participants were followed for a median of 7.7 years until March 2017 and separated into four groups based on baseline serum creatinine levels: less than 0.7 mg/dL (n = 1,492; mean age, 44.9 years), 0.7 mg/dL to 0.79 mg/dL (n = 6,405; mean age, 42.6 years), 0.8 mg/dL to 0.89 mg/dL (n = 10,848; mean age, 42.1 years) and 0.9 mg/dL to 1.2 mg/dL (n = 12,598; mean age, 43.6 years).

The team assessed the levels of serum creatinine using the enzymatic method and identified 2,509 cases of diabetes in the study cohort. The plasma glucose was measured using either the enzymatic or glucose oxidase peroxidative electrode method. HbA1c was measured using a latex agglutination immunoassay, high-performance liquid chromatography, or the enzymatic method. They defined diabetes as either HbA1c levels ≥6.5%, random glucose levels ≥200 mg/dL, fasting glucose levels ≥126 mg/dL or receiving antidiabetic treatment. The participants who met any of the aforementioned conditions during follow up were treated as incident cases of type 2 diabetes.

Men with serum creatinine levels of less than 0.7 mg/dL were at the highest risk for the condition (HR = 1.56)) compared with men with levels of 0.9 mg/dL to 1.2 mg/dL even after adjustments for age, smoking status, BMI, hypertension and dyslipidemia. Men with serum creatinine levels of 0.7 mg/dL to 0.79 mg/dL (HR = 1.22 and 0.8 mg/dL to 0.89 mg/dL (HR = 1.06) also were at higher fully adjusted risk compared with men with levels of 0.9 mg/dL to 1.2 mg/dL. The scientists further observed that men who were aged 45 years or older had higher risk in all creatinine groups compared with men who were younger than 45 years.

The team concluded that in their study based on repeated measurements of serum creatinine shows that low serum creatinine is associated with an increased risk of diabetes. Screening serum creatinine levels can be used to identify those at a high risk of diabetes. Huanhuan Hu, PhD, the lead author of study, said, “Skeletal muscle is a primary target for insulin action. Thus, decreased skeletal muscle mass could potentially trigger insulin resistance, which is an underlying mechanism of diabetes.” The study was published originally published on February 12, 2019, in the Journal of Diabetes Investigation.

Related Links:
National Center for Global Health and Medicine


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Portable Electronic Pipette
Mini 96
New
Silver Member
PCR Plates
Diamond Shell PCR Plates
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.